OraCoat® XyliMelts® Reduce Dry Mouth for Oral Cancer Patients
All-Natural Dry Mouth Remedy Can Help Reduce
Xerostomia in Oral Cancer Patients Undergoing Chemo and Radiation Therapy Treatments
Bellevue,
WA (March 6, 2017) – OraCoat® XyliMelts® help oral cancer
patients suffering from dry mouth as a result of chemotherapy and radiation
treatments.
Xerostomia, more commonly known as dry
mouth, is the subjective sensation of dryness experienced when an insufficient
amount of saliva is produced. While mild or occasional oral dryness occurring
especially during sleep is considered normal in healthy individuals, excessive
ongoing dryness leads to, among other things, disturbed sleep, difficulty
chewing and swallowing, tongue roughness, frequently drinking liquids at night,
and rampant tooth decay.
Dry mouth is exacerbated in cancer patients
because chemotherapy or radiation treatments can impede salivary gland
production, resulting in lower levels of saliva and increased symptoms of dry
mouth. In some cases, this condition is only temporary and will dissipate after
a few months once treatment has been completed and the salivary glands have had
a chance to regenerate and begin functioning properly again. However, in some
cases, the dry mouth becomes a chronic issue for those who received this
treatment.
XyliMelts is a patented dry
mouth product that sticks to the gums on the outside of a molar, releasing
one-half gram of Xylitol, which stimulates saliva flow via a sweet flavor,
reduces dry mouth, and may reduce the risk of tooth decay as well. Xylitol,
slowly released in the mouth so it lingers, is most effective for reducing
xerostomia and reducing the risk of tooth decay. XyliMelts used at night while
sleeping is the most effective per gram delivery of Xylitol.*
Oral cancer patients can use many products
to combat dry mouth, such as sugarless candies to stimulate saliva, but
XyliMelts is the only product designed for use while sleeping which is when dry
mouth is worst.* “XyliMelts provide people affected by oral cancer with an
all-natural, effective remedy for alleviating xerostomia symptoms,” stated Jeff
Haley, founder and Chief Scientist of OraCoat. “Although increasing fluid
intake, regularly flossing, and using mouth washes can assist in reducing
problems of dry mouth, by applying XyliMelts discs on a nightly basis, oral
cancer sufferers can reduce sleep disruption and wake up free of cotton mouth.”
In a March 2016 Clinicians Report® survey of dentists published by CR
Foundation, an independent, non-profit, dental education and product testing
foundation, 152 dentists who were familiar with OraCoat XyliMelts rated it more
effective than any other remedy for dry mouth, including prescription drugs
which came in second.†
XyliMelts are
available over the counter at CVS and Rite Aid. For more information on
XyliMelts, visit www.oracoat.com.
A companion product to XyliMelts for oral
cancer patients is XyliGel®, a soothing gel with 17% Xylitol
buffered to pH 7.4 to relieve dry mouth. It works especially well for people
with very low levels of saliva. XyliGel is available online at oracoat.com.
*Documentation
of these statements available upon request.
†Survey of 1168 dentists, March 2016 Clinicians Report®, an independent, non-profit, dental
education and product testing foundation.
About OraCoat
OraCoat is a
division of OraHealth Corporation, the world leader
in the breakthrough technology of “oral adhering discs” which slowly release
ingredients in the mouth and are safe for use while sleeping. The OraCoat® brand represents a family of products that solve oral care
problems by coating the mouth with safe ingredients that become effective when they are slowly
released. Our flagship product is XyliMelts® for Dry Mouth, an OTC product. Other oral care solutions in
the OraCoat family are planned. OraCoat’s innovative oral care
solutions are backed by careful research based on medical science to ensure
optimum performance and user safety.
# # #
Comments